← Leaderboards
Marisa L. Zallocchi
Ting Therapeutics, Inc.
$2,621,481
Attributed
$2,621,481
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $581.1K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,621,481 · 5
By mechanism
R01$1,592,268 · 2
R44$566,238 · 1
R43$462,975 · 2
Top collaborators
No co-investigators on record.
Most similar at Ting Therapeutics, Inc.
Same institution · by research overlap
- Yunlong Huang$2,977,591
Others in their field
Other Emerging Leaders on “Animals”
- Kevin Urdahl · Seattle Children'S Hospital$84,741,409
- Ted Ross · University Of Georgia$70,992,558
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,986,959
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$49,241,299
Research focus
AnimalsHair CellsHearing ImpairmentMorphologyAffectZebrafishCochleaLabyrinthHigh Throughput ScreeningIn VivoPharmaceutical PreparationsPreclinical TrialGlutathione Metabolism PathwayHigh-Frequency Hearing LossMouse ModelNoiseDoseCell DeathFutureHearingBaseAntioxidantsAdultOtoprotectant
Grant awards (6)
Natural-based therapies for sensory disorders$581,105
R01 · FY2025 · DC · contact PI
Identification and characterization of novel functions for the Usher proteins in the inner ear$491,052
R01 · FY2024 · DC · contact PI
Identification and characterization of novel functions for the Usher proteins in the inner ear$520,111
R01 · FY2023 · DC · contact PI
CDK2 inhibitors for protecting hearing loss$566,238
R44 · FY2022 · DC · contact PI
Therapeutics to prevent aminoglycoside-induced hearing loss$242,322
R43 · FY2020 · DC · contact PI
CDK2 inhibitors for protecting hearing loss$220,653
R43 · FY2020 · DC · contact PI